A Low Dose of Hydrous Icaritin Nano-Formulation with Remarkable Efficacy and Tumor Targeting in Cancer Therapy.

Fu, Jingxin; Wang, Yian; Li, Haowen; Lu, Likang; Ao, Hui; Han, Meihua; Guo, Yifei; Wang, Xiangtao

Fu, Jingxin; Wang, Yian; Li, Haowen; Lu, Likang; Ao, Hui; Han, Meihua; Guo, Yifei; Wang, Xiangtao.

Affiliation

Fu J; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Wang Y; Shenzhen Longhua NO. 3 Foreign Languages School, Shenzhen, 518000, China.
Li H; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Lu L; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Ao H; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Han M; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Guo Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Wang X; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.

J Biomed Nanotechnol ; 17(10): 2003-2013, 2021 Oct 01.

Article in En | MEDLINE | ID: mdl-34706800

Subject(s)

Nanoparticles; Neoplasms; Cell Line, Tumor; Flavonoids; Humans; Neoplasms/drug therapy; Paclitaxel; Particle Size

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Biomed Nanotechnol Year: 2021 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google